Llwytho...
Development of PROSTVAC immunotherapy in prostate cancer
PROSTVAC immunotherapy is a heterologous prime-boost regimen of two different recombinant pox-virus vectors; vaccinia as the primary immunotherapy, followed by boosters employing fowlpox, to provoke immune responses against prostate-specific antigen. Both vectors contain transgenes for prostate-spec...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Future Oncol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4544699/ https://ncbi.nlm.nih.gov/pubmed/26235179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/fon.15.120 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|